ketanserin has been researched along with Kidney Failure in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Papanikolaou, N | 1 |
Darlametsos, I | 1 |
Tsipas, G | 1 |
Morphake, P | 1 |
Bokas, S | 1 |
Gkikas, G | 1 |
Hornych, A | 1 |
Bariety, J | 1 |
Gkika, EL | 1 |
Karageorgou, I | 1 |
Patsialos, K | 1 |
1 other study available for ketanserin and Kidney Failure
Article | Year |
---|---|
Effects of OKY-046 and nifedipine in cyclosporine-induced renal dysfunction in rats.
Topics: Animals; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Interactions; Eicosanoids; Enzyme | 1996 |